Gupta S, Konradt C, Corken A, Ware J, Nieswandt B, Di Paola J
Proc Natl Acad Sci U S A. 2020; 117(39):24316-24325.
PMID: 32929010
PMC: 7533880.
DOI: 10.1073/pnas.2007642117.
Liu M, Wei W, Stone C, Zhang L, Tian G, Ding J
Neuropsychiatr Dis Treat. 2018; 14:787-797.
PMID: 29588593
PMC: 5859911.
DOI: 10.2147/NDT.S157441.
Wolf K, Braun A, Haining E, Tseng Y, Kraft P, Schuhmann M
PLoS One. 2016; 11(1):e0147664.
PMID: 26800051
PMC: 4723080.
DOI: 10.1371/journal.pone.0147664.
STACEY R
Br J Pharmacol Chemother. 2008; 16(3):284-95.
PMID: 19108152
PMC: 1482019.
DOI: 10.1111/j.1476-5381.1961.tb01087.x.
Green A
Br J Pharmacol. 2008; 154(8):1583-99.
PMID: 18516072
PMC: 2518468.
DOI: 10.1038/bjp.2008.207.
THE EFFECTS OF DRUGS ON THE UPTAKE OF AMINES BY MAST CELLS.
Day M, STOCKBRIDGE A
Br J Pharmacol Chemother. 1964; 23:405-19.
PMID: 14228141
PMC: 1704103.
DOI: 10.1111/j.1476-5381.1964.tb01597.x.
[SEROTONIN DETERMINATION IN THROMBOCYTES AND THROMBOCYTE FRACTIONS].
Schulz H, Strobach H, HIEPLER E
Klin Wochenschr. 1964; 42:232-6.
PMID: 14169593
DOI: 10.1007/BF01487949.
EFFECTS OF INORGANIC IONS AND OF PLASMA PROTEINS ON THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE.
Born G, Cross M
J Physiol. 1964; 170:397-414.
PMID: 14165175
PMC: 1368824.
DOI: 10.1113/jphysiol.1964.sp007340.
THE AGGREGATION OF BLOOD PLATELETS.
Born G, Cross M
J Physiol. 1963; 168:178-95.
PMID: 14056485
PMC: 1359417.
DOI: 10.1113/jphysiol.1963.sp007185.
The uptake of biogenic amines by neoplastic mast cells in culture.
Day M, Green J
J Physiol. 1962; 164:227-37.
PMID: 14025622
PMC: 1359299.
DOI: 10.1113/jphysiol.1962.sp007016.
Determination of human platelet survival utilizing C-14-labeled serotonin.
HEYSSEL R
J Clin Invest. 1961; 40:2134-42.
PMID: 13907152
PMC: 290921.
DOI: 10.1172/JCI104439.
The fate of 5-hydroxytryptamine in a smooth muscle and in connective tissue.
Born G
J Physiol. 1962; 161:160-74.
PMID: 13871376
PMC: 1359600.
DOI: 10.1113/jphysiol.1962.sp006879.
Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets.
Born G, Grignani G, Martin K
Br J Clin Pharmacol. 1980; 9(4):321-5.
PMID: 7378248
PMC: 1429986.
DOI: 10.1111/j.1365-2125.1980.tb01057.x.
Applicability of models for carrier-mediated serotonin transport to pools of serotonin in intact human platelets.
Costa J, Murphy D, Stark H
J Physiol. 1981; 316:153-61.
PMID: 7320861
PMC: 1248141.
DOI: 10.1113/jphysiol.1981.sp013779.
The active uptake of serotonin by platelets of schizophrenic patients and their families: possibility of a genetic marker.
Rotman A, Zemishlany Z, Munitz H, WIJSENBEEK H
Psychopharmacology (Berl). 1982; 77(2):171-4.
PMID: 6812135
DOI: 10.1007/BF00431943.
Loss of 5-hydroxytryptamine from mammalian circulating labelled platelets.
Osim E, Wyllie J
J Physiol. 1983; 340:77-90.
PMID: 6411907
PMC: 1199197.
DOI: 10.1113/jphysiol.1983.sp014750.
beta-Endorphin-induced release of 5-hydroxytryptamine from human platelets.
Rolf L, Brune G
Psychopharmacology (Berl). 1981; 73(1):48-50.
PMID: 6262849
DOI: 10.1007/BF00431100.
Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
Magnussen I, VAN WOERT M
Eur J Clin Pharmacol. 1982; 23(1):81-6.
PMID: 6182005
DOI: 10.1007/BF01061381.
The effect of 5-hydroxytryptamine on the potassium exchange of human platelets.
Born G
J Physiol. 1967; 190(2):273-80.
PMID: 6048996
PMC: 1365292.
DOI: 10.1113/jphysiol.1967.sp008207.
Alterations of platelet ultrastructure in patients with carcinoid syndrome.
White J, Davis R
Am J Pathol. 1969; 56(3):519-31.
PMID: 5822315
PMC: 2013588.